ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006